⌘K

Home/Filings/4/0001144204-15-006841

4//SEC Filing

ENDOCYTE INC 4

Accession 0001144204-15-006841

CIK 0001235007operating

View on SEC.gov Company Profile

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 8:00 PM ET

Size

7.1 KB

Accession

0001144204-15-006841

Insider Transaction Report

Form 4

Period: 2015-02-04

ENDOCYTE INCECYT

DirectorPresident and CEO

Transactions

Award
Common Stock
2015-02-04+26,875→ 252,840 total
Award
Stock Option (right to buy)
2015-02-04+161,250→ 161,250 total
Exercise: $5.10Exp: 2025-02-04→ Common Stock (161,250 underlying)

Footnotes (2)

[F1]Represents restricted stock units that will vest and be paid 1/3 annually over a period of 3 years beginning on February 4, 2016, in the form of one share of common stock for each restricted stock unit.
[F2]Shares subject to the option vest 1/3 annually over a period of 3 years beginning on February 4, 2016.

Documents

1 file

4
v400756_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ENDOCYTE INC

CIK 0001235007

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001235007

Filing Metadata

Form type: 4
Filed: Feb 5, 7:00 PM ET
Accepted: Feb 6, 8:00 PM ET
Size: 7.1 KB

View on SEC.gov